[1] Nguyen MH, Wong G, Gane E, et al. Hepatitis B virus: Advances in prevention, diagnosis, and therapy. Clin Microbiol Rev, 2020, 33(2):e00046-19. [2] Tan M, Bhadoria AS, Cui F, et al. Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol, 2021, 6(2):106-119. [3] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版). 实用肝脏病杂志, 2020, 23(1):1-24. [4] Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol, 2019, 16(10):589-604. [5] 中国肝炎防治基金会,中华医学会感染病学分会,中华医学会肝病学分会和中国研究型医院学会肝病专业委员会.瞬时弹性成像技术诊断肝纤维化专家共识(2018年更新版). 中华肝脏病杂志,2019,27(3):182-191. [6] Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 2018,67(4):1560-1599. [7] 张昕, 郭悦, 杨军. 瞬时弹性成像测定肝脾硬度值评估乙型肝炎肝硬化患者食管静脉曲张初步研究. 实用肝脏病杂志, 2021, 24(1): 95-98. [8] Wang H, Wen B, Chang X, et al. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis. J Hepatol, 2021,74(3):584-592. [9] Janik MK, Kruk B, Szczepankiewicz B, et al. Measurement of liver and spleen stiffness as complementary methods for assessment of liver fibrosis in autoimmune hepatitis. Liver Int, 2021, 41(2):348-356. [10] 中华医学会感染病学分会,中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版). 临床肝胆病杂志, 2019, 35(12):41-62. [11] 梁程飞, 常宇南, 彭小蓉, 等. 慢性乙型肝炎儿童肝脏病理特征分析及其肝纤维化非侵入性指标探索. 中华肝脏病杂志, 2021, 29(6): 551-557. [12] 宋凯敏, 刘俊. 瞬时弹性成像技术在慢性乙型肝炎中的应用进展. 临床肝胆病杂志, 2021, 37(2): 419-424. [13] Oeda S, Tanaka K, Oshima A, et al. Diagnostic accuracy of FibroScan and factors affecting Measurements. Diagnostics (Basel), 2020,10(11):940. [14] He T, Li J, Ouyang Y, et al. FibroScan Detection of fatty liver/liver fibrosis in 2266 cases of chronic Hepatitis B. J Clin Transl Hepatol, 2020, 8(2):113-119. [15] 方钟, 王丛, 黄玉仙, 等. 慢性乙型肝炎血清标志物和肝功能指标在不同性别患者间的差异分析. 肝脏, 2021, 26(2): 128-130,139. [16] Huang LL, Yu XP, Li JL, et al. Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection. World J Gastroenterol, 2021, 27(7):641-653. [17] European Association for Study of Liver; Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol, 2015, 63(1):237-264. [18] 折文利, 李新, 刘芳, 等. 弹性成像超声,APRI指数和HA诊断慢性乙肝患者肝纤维化程度的价值. 现代消化及介入诊疗, 2020, 25(3): 395-399. [19] Dong XQ, Wu Z, Li J, et al. Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study. J Gastroenterol Hepatol,2019, 34(4):755-763. |